News
It is the first ever novel food approved in Spain. It is also a worlds first, because it is the first ingredient considered useful to preserve joint health. The rooster comb extract could be added to everyday consumption products such as milk, yoghurt or cheese. Bioiberica will sell it under the trademark Mobilee.
It is the first DNA test that predicts predisposition to rapid progression knee osteoarthritis.This award recognizes the research and innovation of the Spanish biotech company Bioiberica Farma, as well as their contribution to the improvement in the quality of life of Osteoarthritis (OA) patients.
The percentage of patients is even higher among those taking anti-inflammatory or COX-2 inhibitors to treat their osteoarthritis. Physicians still fail to take into account co-morbidity and risk factors associated withosteoarthritis. They are not aware of the risks associated withthe prescription of certain drugs.
A Phase IV, randomized, double blind, placebo controlled clinical test was presented at the 21st National congress of the Spanish Society of Clinical pharmacology. The procedure consisted of applying a painful stimulus to the patients knees, then used functional magnetic resonance to measure the brains reaction to pain.
Recent studies have proved that osteoarthritis (OA) triples with the onset of menopause because of the decrease in estrogen levels. In many cases, it is the gynecologist who must identify the first symptoms of the disease.Today at Cordoba, the president of the 2nd GINEP scientific meeting, Dr. Santiago Palacios, will present Arthrotest the new DNA test that predicts the evolution of knee OA.